While the Shh pathway is closely associated with CSCs, which represent less than 1% of tumor cells, the majority of NSCLC cells show positive Gli1 and Gli2 expression by immunohistochemistry [5, 69, 70], suggesting a complex mechanism of Shh pathway activation in NSCLC. The gene discussed is SHH; the disease is non-small cell lung carcinoma.